DailyStocks Stock Article Search

https://www.fool.com/investing/2024/08/13/the-next-big-biotech-stock-boom-will-be-longevity/?source=iedfolrf0000001 Aug 13, 2024 - Investing based on the segment's long-term prospects is likely to be very lucrative. 0

https://www.zacks.com/stock/news/2321469/here-s-how-to-play-novo-nordisk-nvo-after-q2-earnings-miss?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2321469 Aug 13, 2024 - Novo Nordisk (NVO) is an excellent stock to buy for long-term gains, driven by the stellar performance of its GLP-1 drugs. New investors should utilize the existing opportunity to make an entry. 0

https://www.zacks.com/stock/news/2321388/3-big-drug-stocks-to-watch-on-raised-2024-earnings-sales-view?cid=CS-ZC-FT-analyst_blog|investment_ideas-2321388 Aug 13, 2024 - Here we discuss three drugmakers, Eli Lilly and Company (LLY), Pfizer (PFE) and AbbVie (ABBV), following their increase in sales and earnings guidance for 2024. 0

https://www.zacks.com/stock/news/2321243/wall-street-analysts-see-lilly-lly-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2321243 Aug 13, 2024 - According to the average brokerage recommendation (ABR), one should invest in Lilly (LLY). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock? 0

https://www.fool.com/investing/2024/08/13/this-1-piece-good-news-for-eli-lilly-is-bad-news-f/?source=iedfolrf0000001 Aug 13, 2024 - A company's investments can easily ruin the plans of its competitors. 0

https://www.zacks.com/stock/news/2320553/international-markets-and-lilly-lly-a-deep-dive-for-investors?cid=CS-ZC-FT-fundamental_analysis|nfm_international_revenues-2320553 Aug 12, 2024 - Review Lilly's (LLY) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock. 0

https://www.fool.com/investing/2024/08/12/prediction-buying-biotech-and-pharma-stocks-during/?source=iedfolrf0000001 Aug 12, 2024 - There isn't much to suggest these businesses are actually vulnerable. 0

https://www.zacks.com/stock/news/2319903/pharma-stock-roundup-lly-nvo-bayry-q2-earnings-mrk-s-new-deal-other-updates?cid=CS-ZC-FT-analyst_blog|stock_roundup-2319903 Aug 09, 2024 - Eli Lilly (LLY), Novo Nordisk (NVO) and Bayer (BAYRY) announce second-quarter results. Merck (MRK) expands existing co-development deal with partner Daiichi Sankyo. 0

https://www.zacks.com/stock/news/2319896/company-news-for-aug-9-2024?cid=CS-ZC-FT-corporate_summary-2319896 Aug 09, 2024 - Companies in The News Are: CYBR, PH, LLY, DDOG 0

https://www.fool.com/investing/2024/08/09/prediction-this-weight-loss-stock-will-be-acquired/?source=iedfolrf0000001 Aug 09, 2024 - Altimmune is a little-known pharmaceutical company looking to disrupt the weight loss space. 0